Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial

CONCLUSIONS: This trial indicates that orlistat and acarbose can be successfully combined in a modified-release formulation to provide efficacious weight loss with no unexpected safety issues. EMP16 may be a promising candidate among other medications for improved weight management.PMID:36123783 | DOI:10.1002/oby.23557

Source: Obesity - September 20, 2022 Category: Eating Disorders & Weight Management Authors: Ulf Holmb äck Stefan Grud én Helena Litorp Daniel Willhems Sandra Kuusk G öran Alderborn Arvid S öderhäll Anders Forslund Source Type: research